维普期刊资源整合服务平台（V6.5）

160篇 您的检索式：作者名="Simms M"

选中清除导出查看参考文献查看引证文献引用追踪共8页首页上一页第1页下一页末页 /8 跳转

	题名	作者	年代	出处	被引量
1	Risk stratification for ST segment elevation myocardial infarction in the era of primary percutaneous coronary intervention显示文摘Acute coronary syndromes presenting with ST elevation are usually treated with emergency reperfusion/revascularisation therapy. In contrast current evidence and national guidelines recommend risk stratification for non ST segment elevation myocardial infarction(NSTEMI) with the decision on revascularisation dependent on perceived clinical risk. Risk stratification for STEMI has no recommendation. Statistical risk scoring techniques in NSTEMI have been demonstrated to improve outcomes however their uptake has been poor perhaps due to questions over their discrimination and concern for application to individuals who may not have been adequately represented in clinical trials. STEMI is perceived to carry sufficient risk to warrant emergency coronary intervention [by primary percutaneous coronary intervention(PPCI)] even if this results in a delay to reperfusion with immediate thrombolysis. Immediate thrombolysis may be as effective in patients presenting early, or at low risk, but physicians are poor at assessing clinical and procedural risks and currently are not required to consider this. Inadequate data on risk stratification in STEMI inhibits the option of immediate fibrinolysis, which may be cost-effective. Currently the mode of reperfusion for STEMI defaults to emergency angiography and percutaneous coronary intervention ignoring alternative strategies. This review article examines the current risk scores and evidence base for risk stratification for STEMI patients. The requirements for an ideal STEMI risk score are discussed.	Richard A Brogan Christopher J Malkin Philip D Batin Alexander D Simms James M McLenachan Christopher P Gale	2014	World Journal of Cardiology2014，6，8：	6
2	Surgical treatment of the neuroischemic foot显示文摘	Simms M	2009	J Cardiovasc Surg(Torino)2009，50，3：	1
3	Increased gut-derived norepinephrine release in sepsis:up-regulation of intestinal tyrosine hydroxylase显示文摘	Zhou M Simms HH Wang P	2004	Biochimica et Biophysica Acta2004，1689，：	1
4	Nephronophthisis: a genetically diverse ciliopathy 显示文摘	SIMMS R J HYNES A M ELEY L	2011	Int J Nephrol2011，2011，52：	1
5	Biochemical characterization of the acquired metallo-beta-lactamase SPM-1 from Pseudomonas aeruginosa显示文摘	MURPHY T A SIMM A M TOLEMAN M A	2003	Antimicrob Agents Chemother2003，47，2：	1
6	Biochemical characterization of the acquired metallo-13-1aetamase SPM-1 from Pseudomonas aeruginosa 显示文摘	Murphy T A Simm A M Toleman M A	2003	Antimicrob Agents Chemother2003，47，2：	1
7	MUC1 mucin as a tumor marker in bladder cancer显示文摘	Simms MS Hughes OD Limb M	1999	BJU Int1999，84，3：	1
8	Measurement of THM and precursor concentrations revisited: the effect of bromide ion 显示文摘	Simons J M Kranser S W Simms L A	1993	Journal of American Water Works Association1993，85，：	1
9	MUC1 mucin as a tumour marker in bladder cancer显示文摘	Simms M S Hughes O D Limb M	1999	BJU Int1999，84，3：	1
10	GGDEF and EAL domains inversely regulate cyclic di- GMP levels and transition from sessility to motili- ty显示文摘	SIMM R MORR M KADER A	2004	Mol Microbiol2004，53，4：	1
11	Reduced alpha-defensinexpression is associated with inflammation and not NOD2 mutationstatus in ileal Crohn’s disease显示文摘	Simms L A Doecke J D Walsh M D	2008	Gut2008，57，7：	1
12	Molecular characterization of SPM-1, novel metallo-beta-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance program 显示文摘	Toleman M A Simm A M Murphy T A	2002	J Antimicrob Chemother2002，50，：	1
13	Wind tunnel testing of NREL' s unsteady aerodynamics experiment 显示文摘	FINGERSH L J SIMMS D HAND M	2001	AIAA paper2001，，：	1
14	Expanded molecular diversity generation during directed evolution by trinucleotide exchange (TriNEx) 显示文摘	Baldwin A J Busse K Simm A M	2008	Nucleic Acids Research2008，36，13：	1
15	Production and characterization of 188Re-C595 antibody for radioimmunotherapy of transitional cell bladder cancer显示文摘	Murray A Simms M S Scholfield D P	2001	J Nucl Med2001，42，5：	1
16	Recent advances in the application membrane technology to the treatment of produced water in Canada 显示文摘	SIMMS K M LIU T H ZAIDI S A	1995	Water Treatment1995，10，：	1
17	Customized rapid subtraction hybridization (RASH) gene mi- croarrays identify overlapping expression changes in human fe- tal astrocytes resulting from human immunodeficiency virus-1 infection or tumor necrosis facto-alpha treatment 显示文摘	Su Z Z Chen Y Kang D C Chao W Simm M Volsky D J	2003	Gene2003，306，：	1
18	99mTechnetiumC595 radioimmunoscintigraphy:a potential staging tool for bladder cancer显示文摘	Simms M S Perkins A C Price M R	2001	BJU Int2001，88，7：	1
19	Treatment of 100 patientswith primary amyloidosis:a randomized trial of melphalan,pred2nisone,and colchicine versus colchicine only显示文摘	Skinner M Anderson J Simms R	1996	Am J Med1996，100，：	1
20	Complex interplay between type 1 fimbrial expression and flagellum - mediated motility of uropathogenic Escherichia coli显示文摘	M Chelsea Lane Amy N Simms Harry LT Mobley	2007	J Bacteriol2007，189，：	1

返回顶部每页显示：

共8页首页上一页第1页下一页末页 /8 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示